Targacept, Inc. to Present at the 2012 Deutsche Bank dbAccess BioFEST

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that members of its executive management are scheduled to present at the 2012 Deutsche Bank dbAccess BioFEST at Four Seasons Hotel Boston on Tuesday, December 4, 2012 at 4:00 p.m. Eastern Time. The presentation will be webcast and accessible from the Investor Relations page of Targacept’s website, www.targacept.com. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes prior to the scheduled start time. An archived version of the webcast will be available for replay on the Investor Calendar section of the Investor Relations page of Targacept’s website for at least two weeks following the event.